• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞端粒长度变异性作为多聚谷氨酰胺疾病患者的潜在生物标志物

Leukocyte Telomere Length Variability as a Potential Biomarker in Patients with PolyQ Diseases.

作者信息

Scarabino Daniela, Veneziano Liana, Fiore Alessia, Nethisinghe Suran, Mantuano Elide, Garcia-Moreno Hector, Bellucci Gianmarco, Solanky Nita, Morello Maria, Zanni Ginevra, Corbo Rosa Maria, Giunti Paola

机构信息

Institute of Molecular Biology and Pathology, National Research Council, 00185 Rome, Italy.

Institute of Translational Pharmacology, National Research Council, 00133 Rome, Italy.

出版信息

Antioxidants (Basel). 2022 Jul 24;11(8):1436. doi: 10.3390/antiox11081436.

DOI:10.3390/antiox11081436
PMID:35892638
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9332235/
Abstract

SCA1, SCA2, and SCA3 are the most common forms of SCAs among the polyglutamine disorders, which include Huntington's Disease (HD). We investigated the relationship between leukocyte telomere length (LTL) and the phenotype of SCA1, SCA2, and SCA3, comparing them with HD. The results showed that LTL was significantly reduced in SCA1 and SCA3 patients, while LTL was significantly longer in SCA2 patients. A significant negative relationship between LTL and age was observed in SCA1 but not in SCA2 subjects. LTL of SCA3 patients depend on both patient's age and disease duration. The number of CAG repeats did not affect LTL in the three SCAs. Since LTL is considered an indirect marker of an inflammatory response and oxidative damage, our data suggest that in SCA1 inflammation is present already at an early stage of disease similar to in HD, while in SCA3 inflammation and impaired antioxidative processes are associated with disease progression. Interestingly, in SCA2, contrary to SCA1 and SCA3, the length of leukocyte telomeres does not reduce with age. We have observed that SCAs and HD show a differing behavior in LTL for each subtype, which could constitute relevant biomarkers if confirmed in larger cohorts and longitudinal studies.

摘要

SCA1、SCA2和SCA3是聚谷氨酰胺疾病中最常见的脊髓小脑共济失调(SCA)形式,聚谷氨酰胺疾病包括亨廷顿舞蹈症(HD)。我们研究了白细胞端粒长度(LTL)与SCA1、SCA2和SCA3表型之间的关系,并将它们与HD进行比较。结果显示,SCA1和SCA3患者的LTL显著缩短,而SCA2患者的LTL显著更长。在SCA1患者中观察到LTL与年龄之间存在显著负相关,而在SCA2患者中未观察到这种相关性。SCA3患者的LTL取决于患者的年龄和病程。CAG重复序列的数量在这三种脊髓小脑共济失调中不影响LTL。由于LTL被认为是炎症反应和氧化损伤的间接标志物,我们的数据表明,在SCA1中,炎症在疾病早期就已存在,类似于HD,而在SCA3中,炎症和抗氧化过程受损与疾病进展相关。有趣的是,与SCA1和SCA3相反,在SCA2中,白细胞端粒的长度不会随着年龄的增长而缩短。我们观察到,每种亚型的脊髓小脑共济失调和HD在LTL方面表现出不同的行为,如果在更大的队列和纵向研究中得到证实,这可能构成相关的生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b571/9332235/3dd968c8b121/antioxidants-11-01436-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b571/9332235/2dc4dbc3fae8/antioxidants-11-01436-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b571/9332235/6e9d051e6cf7/antioxidants-11-01436-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b571/9332235/6039c4073610/antioxidants-11-01436-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b571/9332235/4a70e671c5a2/antioxidants-11-01436-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b571/9332235/dbecbe8427a5/antioxidants-11-01436-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b571/9332235/bc399f87ae8f/antioxidants-11-01436-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b571/9332235/af6388d422c4/antioxidants-11-01436-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b571/9332235/3dd968c8b121/antioxidants-11-01436-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b571/9332235/2dc4dbc3fae8/antioxidants-11-01436-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b571/9332235/6e9d051e6cf7/antioxidants-11-01436-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b571/9332235/6039c4073610/antioxidants-11-01436-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b571/9332235/4a70e671c5a2/antioxidants-11-01436-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b571/9332235/dbecbe8427a5/antioxidants-11-01436-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b571/9332235/bc399f87ae8f/antioxidants-11-01436-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b571/9332235/af6388d422c4/antioxidants-11-01436-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b571/9332235/3dd968c8b121/antioxidants-11-01436-g008.jpg

相似文献

1
Leukocyte Telomere Length Variability as a Potential Biomarker in Patients with PolyQ Diseases.白细胞端粒长度变异性作为多聚谷氨酰胺疾病患者的潜在生物标志物
Antioxidants (Basel). 2022 Jul 24;11(8):1436. doi: 10.3390/antiox11081436.
2
Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.将脊髓小脑共济失调 1、2、3、6 型的风险个体转化为显性共济失调(RISCA):一项纵向队列研究。
Lancet Neurol. 2020 Sep;19(9):738-747. doi: 10.1016/S1474-4422(20)30235-0.
3
[SCA1, SCA2, MJD/SCA3 (CAG)n mutation detection and analysis in patients with hereditary spinocerebellar ataxia from Chinese families].中国家系遗传性脊髓小脑共济失调患者中SCA1、SCA2、MJD/SCA3(CAG)n突变的检测与分析
Zhonghua Yi Xue Za Zhi. 1997 Nov;77(11):819-22.
4
Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.中国家系遗传性脊髓小脑共济失调患者中SCA1、SCA2、SCA3/MJD、SCA6、SCA7和DRPLA CAG三核苷酸重复扩增的频率
Arch Neurol. 2000 Apr;57(4):540-4. doi: 10.1001/archneur.57.4.540.
5
Analysis of CAG repeats in SCA1, SCA2, SCA3, SCA6, SCA7 and DRPLA loci in spinocerebellar ataxia patients and distribution of CAG repeats at the SCA1, SCA2 and SCA6 loci in nine ethnic populations of eastern India.脊髓小脑共济失调患者中SCA1、SCA2、SCA3、SCA6、SCA7和DRPLA基因座的CAG重复序列分析以及印度东部九个民族群体中SCA1、SCA2和SCA6基因座的CAG重复序列分布。
Hum Genet. 2000 Jun;106(6):597-604. doi: 10.1007/s004390000320.
6
Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.脊髓小脑性共济失调 1、2、3、6 型的长期疾病进展:一项纵向队列研究。
Lancet Neurol. 2015 Nov;14(11):1101-8. doi: 10.1016/S1474-4422(15)00202-1. Epub 2015 Sep 13.
7
Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.在 RISCA 纵向研究中,脊髓小脑共济失调 1、2、3 和 6 型风险个体的生物学和临床特征:基线数据分析。
Lancet Neurol. 2013 Jul;12(7):650-8. doi: 10.1016/S1474-4422(13)70104-2. Epub 2013 May 22.
8
Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort study.脊髓小脑性共济失调 1、2、3、6 型患者的生存情况(EUROSCA):一项纵向队列研究。
Lancet Neurol. 2018 Apr;17(4):327-334. doi: 10.1016/S1474-4422(18)30042-5. Epub 2018 Mar 13.
9
Spinocerebellar ataxias types 1, 2 and 3: age adjusted clinical severity of disease at presentation correlates with size of CAG repeat lengths.脊髓小脑性共济失调1型、2型和3型:就诊时经年龄调整的疾病临床严重程度与CAG重复序列长度相关。
J Neurol Sci. 2009 Feb 15;277(1-2):83-6. doi: 10.1016/j.jns.2008.10.016. Epub 2008 Dec 2.
10
Leukocyte Telomere Length as Potential Biomarker of HD Progression: A Follow-Up Study.白细胞端粒长度作为 HD 进展的潜在生物标志物:一项随访研究。
Int J Mol Sci. 2022 Nov 3;23(21):13449. doi: 10.3390/ijms232113449.

引用本文的文献

1
Maternal stress-induced changes in adolescent and adult offspring: Neurobehavioural improvement and telomere maintenance.母体应激引起的青少年和成年后代变化:神经行为改善与端粒维持。
Heliyon. 2023 Sep 21;9(10):e20385. doi: 10.1016/j.heliyon.2023.e20385. eCollection 2023 Oct.
2
Leukocyte Telomere Length as Potential Biomarker of HD Progression: A Follow-Up Study.白细胞端粒长度作为 HD 进展的潜在生物标志物:一项随访研究。
Int J Mol Sci. 2022 Nov 3;23(21):13449. doi: 10.3390/ijms232113449.

本文引用的文献

1
Effect of oxidative stress on telomere maintenance in aortic smooth muscle cells.氧化应激对主动脉平滑肌细胞端粒维持的影响。
Biochim Biophys Acta Mol Basis Dis. 2022 Jul 1;1868(7):166397. doi: 10.1016/j.bbadis.2022.166397. Epub 2022 Mar 26.
2
Telomere Length and Oxidative Stress and Its Relation with Metabolic Syndrome Components in the Aging.端粒长度与氧化应激及其与衰老过程中代谢综合征各组分的关系。
Biology (Basel). 2021 Mar 24;10(4):253. doi: 10.3390/biology10040253.
3
Leukocyte telomere length and plasma interleukin-1β and interleukin-18 levels in mild cognitive impairment and Alzheimer's disease: new biomarkers for diagnosis and disease progression?
轻度认知障碍和阿尔茨海默病中白细胞端粒长度及血浆白细胞介素-1β和白细胞介素-18水平:诊断及疾病进展的新生物标志物?
Neural Regen Res. 2021 Jul;16(7):1397-1398. doi: 10.4103/1673-5374.300986.
4
Pathomechanism characterization and potential therapeutics identification for SCA3 targeting neuroinflammation.针对神经炎症的 SCA3 的病理机制特征描述和潜在治疗方法的鉴定。
Aging (Albany NY). 2020 Nov 10;12(23):23619-23646. doi: 10.18632/aging.103700.
5
Collaborative Efforts for Spinocerebellar Ataxia Research in the United States: CRC-SCA and READISCA.美国脊髓小脑共济失调研究的合作努力:CRC-SCA和READISCA。
Front Neurol. 2020 Aug 26;11:902. doi: 10.3389/fneur.2020.00902. eCollection 2020.
6
Determinants of telomere length across human tissues.人类组织中端粒长度的决定因素。
Science. 2020 Sep 11;369(6509). doi: 10.1126/science.aaz6876.
7
Aberrant Cerebellar Circuitry in the Spinocerebellar Ataxias.脊髓小脑共济失调中的异常小脑环路。
Front Neurosci. 2020 Jul 16;14:707. doi: 10.3389/fnins.2020.00707. eCollection 2020.
8
Relationship between proinflammatory cytokines (Il-1beta, Il-18) and leukocyte telomere length in mild cognitive impairment and Alzheimer's disease.在轻度认知障碍和阿尔茨海默病中促炎细胞因子(IL-1β、IL-18)与白细胞端粒长度的关系。
Exp Gerontol. 2020 Jul 15;136:110945. doi: 10.1016/j.exger.2020.110945. Epub 2020 Apr 11.
9
Chemoptogenetic damage to mitochondria causes rapid telomere dysfunction.化学遗传学诱导的线粒体损伤导致端粒功能迅速障碍。
Proc Natl Acad Sci U S A. 2019 Sep 10;116(37):18435-18444. doi: 10.1073/pnas.1910574116. Epub 2019 Aug 26.
10
Can leukocyte telomere shortening be a possible biomarker to track Huntington's disease progression?白细胞端粒缩短能否作为追踪亨廷顿舞蹈病进展的潜在生物标志物?
Neural Regen Res. 2019 Oct;14(10):1709-1710. doi: 10.4103/1673-5374.257522.